Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People

  • STATUS
    Recruiting
  • days left to enroll
    24
  • participants needed
    350
  • sponsor
    Abbott Diabetes Care
Updated on 22 October 2022

Summary

A multi-center, randomized, prospective, non-significant risk study to compare the impact of the FreeStyle Libre Flash Glucose Monitoring System with and without a food logging smartphone application on reducing time above 180 mg/dL in subjects with type 2 diabetes who are not adequately controlled on their existing oral anti-diabetes medication regimen.

Description

Approximately 350 subjects will be enrolled to obtain at least 84 randomized subjects,approximately 42 subjects per arm. Subjects will be randomized to use either the FreeStyle Libre Flash Glucose Monitoring System or FreeStyle Libre Flash Glucose Monitoring System with a food logging smartphone application to manage their diabetes.

The subsequent impact on reducing the amount of time spent above 180 mg/dL will be assessed.

Details
Condition Diabetes Mellitus, Type 2
Treatment FreeStyle Libre System, FreeStyle Libre System plus food app
Clinical Study IdentifierNCT04843527
SponsorAbbott Diabetes Care
Last Modified on22 October 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Subject must be at least 18 years of age
Subject has been diagnosed with type 2 diabetes
HbA1c greater than or equal to 7.5% and less than or equal to 12%
Subject is on at least 1 diabetes medication in the classes of metformin, SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors
Subject owns a compatible smartphone
Subject agrees to a 3-month period of no diabetes medication changes
Subject is willing to make diet and lifestyle changes in response to education and glucose data

Exclusion Criteria

Subject is currently on insulin therapy or sulfonylurea-based medications
Subject has known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin
Subject is known to be pregnant at the time of study enrollment (applicable to female subjects only)
Subject has extensive skin changes/diseases at the proposed application sites that could interfere with device placement or the accuracy of interstitial glucose measurements
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note